Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06382818 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Study acronym: PROBA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  2. Primary completion date: Apr 26, 2027 to Mar 6, 2028v2 Show 4 more changesShow less
    • Start date: Apr 26, 2024 to Mar 6, 2025
    • Study completion date: Apr 26, 2036 to Mar 6, 2038
    • Eligibility criteria expanded, about 1 word
    • Study description expanded, about 4 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Our objective is based on a personalized approach of adjuvant breast radiotherapy by selecting patients according to tumor recurrence and toxicity risk.
Trial Details
NCT Number NCT06382818
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 854 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov